Literature DB >> 22523069

Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts.

Arianna Moiani1, Ylenia Paleari, Daniela Sartori, Riccardo Mezzadra, Annarita Miccio, Claudia Cattoglio, Fabienne Cocchiarella, Maria Rosa Lidonnici, Giuliana Ferrari, Fulvio Mavilio.   

Abstract

Retroviral vectors integrate in genes and regulatory elements and may cause transcriptional deregulation of gene expression in target cells. Integration into transcribed genes also has the potential to deregulate gene expression at the posttranscriptional level by interfering with splicing and polyadenylation of primary transcripts. To examine the impact of retroviral vector integration on transcript splicing, we transduced primary human cells or cultured cells with HIV-derived vectors carrying a reporter gene or a human β-globin gene under the control of a reduced-size locus-control region (LCR). Cells were randomly cloned and integration sites were determined in individual clones. We identified aberrantly spliced, chimeric transcripts in more than half of the targeted genes in all cell types. Chimeric transcripts were generated through the use of constitutive and cryptic splice sites in the HIV 5ι long terminal repeat and gag gene as well as in the β-globin gene and LCR. Compared with constitutively spliced transcripts, most aberrant transcripts accumulated at a low level, at least in part as a consequence of nonsense-mediated mRNA degradation. A limited set of cryptic splice sites caused the majority of aberrant splicing events, providing a strategy for recoding lentiviral vector backbones and transgenes to reduce their potential posttranscriptional genotoxicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22523069      PMCID: PMC3347495          DOI: 10.1172/JCI61852

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Authors:  Alessandro Aiuti; Federica Cattaneo; Stefania Galimberti; Ulrike Benninghoff; Barbara Cassani; Luciano Callegaro; Samantha Scaramuzza; Grazia Andolfi; Massimiliano Mirolo; Immacolata Brigida; Antonella Tabucchi; Filippo Carlucci; Martha Eibl; Memet Aker; Shimon Slavin; Hamoud Al-Mousa; Abdulaziz Al Ghonaium; Alina Ferster; Andrea Duppenthaler; Luigi Notarangelo; Uwe Wintergerst; Rebecca H Buckley; Marco Bregni; Sarah Marktel; Maria Grazia Valsecchi; Paolo Rossi; Fabio Ciceri; Roberto Miniero; Claudio Bordignon; Maria-Grazia Roncarolo
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

2.  Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors.

Authors:  Francesca Di Nunzio; Giulietta Maruggi; Stefano Ferrari; Enzo Di Iorio; Valentina Poletti; Marta Garcia; Marcela Del Rio; Michele De Luca; Fernando Larcher; Graziella Pellegrini; Fulvio Mavilio
Journal:  Mol Ther       Date:  2008-09-23       Impact factor: 11.454

3.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

Authors:  Salima Hacein-Bey-Abina; Alexandrine Garrigue; Gary P Wang; Jean Soulier; Annick Lim; Estelle Morillon; Emmanuelle Clappier; Laure Caccavelli; Eric Delabesse; Kheira Beldjord; Vahid Asnafi; Elizabeth MacIntyre; Liliane Dal Cortivo; Isabelle Radford; Nicole Brousse; François Sigaux; Despina Moshous; Julia Hauer; Arndt Borkhardt; Bernd H Belohradsky; Uwe Wintergerst; Maria C Velez; Lily Leiva; Ricardo Sorensen; Nicolas Wulffraat; Stéphane Blanche; Frederic D Bushman; Alain Fischer; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

4.  In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia.

Authors:  Annarita Miccio; Rossano Cesari; Francesco Lotti; Claudia Rossi; Francesca Sanvito; Maurilio Ponzoni; Samantha J E Routledge; Cheok-Man Chow; Michael N Antoniou; Giuliana Ferrari
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

5.  The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.

Authors:  Eugenio Montini; Daniela Cesana; Manfred Schmidt; Francesca Sanvito; Cynthia C Bartholomae; Marco Ranzani; Fabrizio Benedicenti; Lucia Sergi Sergi; Alessandro Ambrosi; Maurilio Ponzoni; Claudio Doglioni; Clelia Di Serio; Christof von Kalle; Luigi Naldini
Journal:  J Clin Invest       Date:  2009-03-23       Impact factor: 14.808

6.  Hot spots of retroviral integration in human CD34+ hematopoietic cells.

Authors:  Claudia Cattoglio; Giulia Facchini; Daniela Sartori; Antonella Antonelli; Annarita Miccio; Barbara Cassani; Manfred Schmidt; Christof von Kalle; Steve Howe; Adrian J Thrasher; Alessandro Aiuti; Giuliana Ferrari; Alessandra Recchia; Fulvio Mavilio
Journal:  Blood       Date:  2007-05-16       Impact factor: 22.113

7.  Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

Authors:  Fulvio Mavilio; Graziella Pellegrini; Stefano Ferrari; Francesca Di Nunzio; Enzo Di Iorio; Alessandra Recchia; Giulietta Maruggi; Giuliana Ferrari; Elena Provasi; Chiara Bonini; Sergio Capurro; Andrea Conti; Cristina Magnoni; Alberto Giannetti; Michele De Luca
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

8.  Overlapping enhancer/promoter and transcriptional termination signals in the lentiviral long terminal repeat.

Authors:  Qing Yang; Aurore Lucas; Sodany Son; Lung-Ji Chang
Journal:  Retrovirology       Date:  2007-01-22       Impact factor: 4.602

Review 9.  The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.

Authors:  Alan Engelman; Peter Cherepanov
Journal:  PLoS Pathog       Date:  2008-03-28       Impact factor: 6.823

10.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.

Authors:  Steven J Howe; Marc R Mansour; Kerstin Schwarzwaelder; Cynthia Bartholomae; Michael Hubank; Helena Kempski; Martijn H Brugman; Karin Pike-Overzet; Stephen J Chatters; Dick de Ridder; Kimberly C Gilmour; Stuart Adams; Susannah I Thornhill; Kathryn L Parsley; Frank J T Staal; Rosemary E Gale; David C Linch; Jinhua Bayford; Lucie Brown; Michelle Quaye; Christine Kinnon; Philip Ancliff; David K Webb; Manfred Schmidt; Christof von Kalle; H Bobby Gaspar; Adrian J Thrasher
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

View more
  66 in total

1.  Gene therapy: too much splice can spoil the dish.

Authors:  Didier Trono
Journal:  J Clin Invest       Date:  2012-04-23       Impact factor: 14.808

2.  Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination.

Authors:  Andrea Coluccio; Francesca Miselli; Angelo Lombardo; Alessandra Marconi; Guidantonio Malagoli Tagliazucchi; Manuel A Gonçalves; Carlo Pincelli; Giulietta Maruggi; Marcela Del Rio; Luigi Naldini; Fernando Larcher; Fulvio Mavilio; Alessandra Recchia
Journal:  Mol Ther       Date:  2013-06-13       Impact factor: 11.454

3.  CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.

Authors:  Daniela Benati; Francesca Miselli; Fabienne Cocchiarella; Clarissa Patrizi; Marta Carretero; Samantha Baldassarri; Virginia Ammendola; Cristina Has; Stefano Colloca; Marcela Del Rio; Fernando Larcher; Alessandra Recchia
Journal:  Mol Ther       Date:  2018-08-04       Impact factor: 11.454

Review 4.  Biosafety features of lentiviral vectors.

Authors:  Axel Schambach; Daniela Zychlinski; Birgitta Ehrnstroem; Christopher Baum
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

5.  Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque.

Authors:  Diego A Espinoza; Xing Fan; Di Yang; Stefan F Cordes; Lauren L Truitt; Katherine R Calvo; Idalia M Yabe; Selami Demirci; Kristin J Hope; So Gun Hong; Allen Krouse; Mark Metzger; Aylin Bonifacino; Rong Lu; Naoya Uchida; John F Tisdale; Xiaolin Wu; Suk See DeRavin; Harry L Malech; Robert E Donahue; Chuanfeng Wu; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2019-04-09       Impact factor: 11.454

6.  Regulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques.

Authors:  Cecilia N Barese; Tania C Felizardo; Stephanie E Sellers; Keyvan Keyvanfar; Antonio Di Stasi; Mark E Metzger; Allen E Krouse; Robert E Donahue; David M Spencer; Cynthia E Dunbar
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

Review 7.  Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.

Authors:  Jakub Tolar; John E Wagner
Journal:  Lancet       Date:  2013-10-05       Impact factor: 79.321

8.  Targeting miR-21 for the therapy of pancreatic cancer.

Authors:  Flavie Sicard; Marion Gayral; Hubert Lulka; Louis Buscail; Pierre Cordelier
Journal:  Mol Ther       Date:  2013-03-12       Impact factor: 11.454

9.  Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.

Authors:  Kerstin B Kaufmann; Christian Brendel; Julia D Suerth; Uta Mueller-Kuller; Linping Chen-Wichmann; Joachim Schwäble; Shweta Pahujani; Hana Kunkel; Axel Schambach; Christopher Baum; Manuel Grez
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

10.  Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature.

Authors:  Reba Condiotti; Daniel Goldenberg; Hilla Giladi; Temima Schnitzer-Perlman; Simon N Waddington; Suzanne Mk Buckley; Denise Heim; Wing Cheung; Matthew Themis; Charles Coutelle; Alina Simerzin; Emma Osejindu; Henning Wege; Michael Themis; Eithan Galun
Journal:  Mol Ther       Date:  2013-08-28       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.